Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice
| Autor: | Akira Yamauchi, Masahiro Yamamura, Keisuke Hino, Kyo Sasaki, Yuichi Hara, Fukuda Kotaro, Sohji Nishina, Kensuke Egashira |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
0301 basic medicine Chemokine Glucose uptake Cell Culture Techniques PLGA poly(lactic-co-glycolic acid) 2-NDBG 2-(N-[nitrobenz-2-oxa1 3-diazol-4-yl]amino)-2-deoxyglucose CD8-Positive T-Lymphocytes TNF-α tumor necrosis factor-α 2DG 2-Deoxy-D-glucose Mice chemistry.chemical_compound Liver Neoplasms Experimental 0302 clinical medicine Polylactic Acid-Polyglycolic Acid Copolymer Antineoplastic Combined Chemotherapy Protocols Warburg Effect Oncologic GSH glutathione Cytotoxic T cell IFN-γ interferon-γ Cytotoxicity Immune Checkpoint Inhibitors IFN-γ Original Research biology Chemistry Programmed Death 1 Liver Neoplasms EZH2 enhancer of zeste homologue 2 Gastroenterology PLGA Drug Synergism CCL C-C motif chemokine mRNA messenger RNA 030211 gastroenterology & hepatology FITC fluorescein isothiocyanate JAK Janus kinase Carcinoma Hepatocellular ATP adenosine triphosphate CCR C-C chemokine receptor type 4 ICG indocyanine green Treg regulatory T cell mTOR mammalian target of rapamycin macromolecular substances Deoxyglucose H3K27me3 H3 lysine 27 trimethylation STAM stelic animal model STAT signal transducers and activator of transcription ER endoplasmic reticulum Interferon-gamma homologue 2 03 medical and health sciences ROS reactive oxygen species FBS fetal bovine serum Cell Line Tumor Animals Humans CXCL10 lcsh:RC799-869 PD1 programmed death 1 18F-FDG 18F-2-fluoro-2-deoxyglucose Hepatology technology industry and agriculture Xenograft Model Antitumor Assays Coculture Techniques AMPK AMP-activated protein kinase PD-L1 programmed death-ligand 1 030104 developmental biology Drug Resistance Neoplasm Cancer cell Cancer research biology.protein Lactate lcsh:Diseases of the digestive system. Gastroenterology Tumor Escape NP nanoparticles Nanoparticle Drug Delivery System HCC hepatocellular carcinoma 2-Deoxy-D-glucose CD8 DAPI 4′ 6-diamidino-2-phenylindole DEN diethylnitrosamine |
| Zdroj: | Cellular and Molecular Gastroenterology and Hepatology Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 3, Pp 739-762 (2021) |
| ISSN: | 2352-345X |
| DOI: | 10.1016/j.jcmgh.2020.10.010 |
| Popis: | Background & Aims Immune checkpoint inhibitors have shed light on the importance of antitumor immunity as a therapeutic strategy for hepatocellular carcinoma (HCC). The altered glucose metabolism known as the Warburg effect recently has gained attention as a cancer immune-resistance mechanism. Considering glycolysis inhibitors as therapeutic agents, their specific delivery to cancer cells is critical not to induce adverse effects. Thus, we investigated antitumor effects of a glycolysis inhibitor, consisting of 2-deoxy-D-glucose (2DG)-encapsulated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (2DG-PLGA-NPs), against hepatocellular carcinoma in mice. Methods The antitumor effects of 2DG-PLGA-NPs were examined using hepatoma cell lines, xenograft tumors, and hepatocarcinogenic and syngeneic mouse models. Results The 2DG-PLGA-NPs induced cytotoxic effects and antitumor immunity through enhanced T-cell trafficking. In addition, 2DG-PLGA-NPs induced decreased lactate production and increased interferon-γ–positive T cells in liver tumors. Human CD8+ T cells cocultured with 2DG-PLGA-NP–treated Huh7 cells showed their increased interferon-γ production and glucose uptake compared with the CD8+ T cells co-cultured with PLGA-NP–treated Huh7 cells. Chemotaxis of CD8+ T cells was suppressed by lactate and enhanced by glucose. Interferon-γ enhanced CD8+ T-cell chemotaxis in both an autocrine and paracrine manner. Notably, the 2DG-PLGA-NPs augmented chemokine (CXCL9/CXCL10) production in liver tumors via interferon-γ–Janus kinase–signal transducers and activator of transcription pathway and 5' adenosine monophosphate-activated protein kinase–mediated suppression of histone H3 lysine 27 trimethylation. These 2DG-PLGA-NPs not only amplified antitumor effects induced by sorafenib or an anti–programmed death-1 antibody, but also suppressed anti–programmed death-1–resistant tumors. Conclusions The newly developed 2DG-PLGA-NPs showed antitumor immunity and cytotoxicity in liver tumors in mice, suggesting the potential of 2DG-PLGA-NPs for future clinical applications. Graphical abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|